BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8406137)

  • 1. Fatty acids as markers of the blood-cerebrospinal fluid barrier function in man.
    Roelcke U; Heil J
    Funct Neurol; 1993; 8(3):189-92. PubMed ID: 8406137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transport and production of cerebrospinal fluid (CSF) change in aging humans under normal and diseased conditions.
    Kleine TO; Hackler R; Lütcke A; Dauch W; Zöfel P
    Z Gerontol; 1993; 26(4):251-5. PubMed ID: 8212795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentrations of hepatocyte growth factor in cerebrospinal fluid under normal and different pathological conditions.
    Kern MA; Bamborschke S; Nekic M; Schubert D; Rydin C; Lindholm D; Schirmacher P
    Cytokine; 2001 May; 14(3):170-6. PubMed ID: 11396995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes of the fatty acids in cerebrospinal fluid in pathological conditions: characteristics of some lipid and lipoprotein fractions].
    Arnetoli G; Cadelo M; Taiuti R; Amaducci L
    Acta Neurol (Napoli); 1972; 27(2):114-20. PubMed ID: 5042256
    [No Abstract]   [Full Text] [Related]  

  • 5. Age-related alterations of the blood-brain-barrier (bbb) permeability to protein molecules of different size.
    Kleine TO; Hackler R; Zöfel P
    Z Gerontol; 1993; 26(4):256-9. PubMed ID: 7692679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age and sex as factors modifying the function of the blood-cerebrospinal fluid barrier.
    Pakulski C; Drobnik L; Millo B
    Med Sci Monit; 2000; 6(2):314-8. PubMed ID: 11208329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-trace protein in cerebrospinal fluid: a blood-CSF barrier-related evaluation in neurological diseases.
    Tumani H; Nau R; Felgenhauer K
    Ann Neurol; 1998 Dec; 44(6):882-9. PubMed ID: 9851432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood-brain barrier dysfunction occurring in mice infected with Angiostrongylus cantonensis.
    Lee JD; Tsai LY; Chen CH; Wang JJ; Hsiao JK; Yen CM
    Acta Trop; 2006 Feb; 97(2):204-11. PubMed ID: 16332352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The pattern of cerebrospinal fluid proteins in infants and children. Determination of normal values (author's transl)].
    Gerbaut L; Ponsot G; Dulac O; Olive G; Arthuis M
    Arch Fr Pediatr; 1981 Jan; 38(1):3-9. PubMed ID: 7224799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-cerebrospinal fluid barrier integrity in cerebral infarction.
    Niebrój-Dobosz I; Mariam AG; Lukasiuk M; Rafałowska J
    Neuropatol Pol; 1992; 30(1):29-33. PubMed ID: 1484607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dysfunction of the blood-brain barrier in patients with acute leukemias or lymphomas of high grade malignancy].
    Zdziarska B; Nowacki P; Millo B
    Acta Haematol Pol; 1995; 26(3):299-304. PubMed ID: 8525776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased CSF/serum albumin ratio: a recurrent finding in violent offenders.
    Anckarsäter H; Forsman A; Blennow K
    Acta Neurol Scand; 2005 Jul; 112(1):48-50. PubMed ID: 15932356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis].
    Drulović J; Stojsavljević N; Dujmović I; Sokić D; Mavra M; Lević Z
    Srp Arh Celok Lek; 1995; 123(7-8):191-3. PubMed ID: 17974427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetranectin in cerebrospinal fluid of patients with multiple sclerosis.
    Stoevring B; Jaliashvili I; Thougaard AV; Ensinger C; Høgdall CK; Rasmussen LS; Sellebjerg F; Christiansen M
    Scand J Clin Lab Invest; 2006; 66(7):577-83. PubMed ID: 17101549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF/serum folate gradient: physiology and determinants with special reference to dementia.
    Hagnelius NO; Wahlund LO; Nilsson TK
    Dement Geriatr Cogn Disord; 2008; 25(6):516-23. PubMed ID: 18463447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Speciation analysis of selected metals and determination of their total contents in paired serum and cerebrospinal fluid samples: An approach to investigate the permeability of the human blood-cerebrospinal fluid-barrier.
    Nischwitz V; Berthele A; Michalke B
    Anal Chim Acta; 2008 Oct; 627(2):258-69. PubMed ID: 18809082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What determines the CSF concentrations of albumin and plasma-derived IgG?
    Seyfert S; Faulstich A; Marx P
    J Neurol Sci; 2004 Apr; 219(1-2):31-3. PubMed ID: 15050434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-brain barrier permeability correlates with medial temporal lobe atrophy but not with amyloid-beta protein transport across the blood-brain barrier in Alzheimer's disease.
    Matsumoto Y; Yanase D; Noguchi-Shinohara M; Ono K; Yoshita M; Yamada M
    Dement Geriatr Cogn Disord; 2007; 23(4):241-5. PubMed ID: 17310121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Function of the blood-cerebrospinal fluid barrier and selected biochemical cerebrospinal fluid components in senile dementias of various types].
    Szilágyi AK; Martini E; Venter V
    Psychiatr Neurol Med Psychol (Leipz); 1986 Jan; 38(1):1-8. PubMed ID: 3961019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow rate of cerebrospinal fluid (CSF)--a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases.
    Reiber H
    J Neurol Sci; 1994 Apr; 122(2):189-203. PubMed ID: 8021703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.